At the request of the corresponding author and investigator at the University of California, San Francisco, and in consultation with Molecular Pharmacology, this paper has been retracted. It was found there was improper manipulation, reuse, and analyses represented by Figs. 1A, 1B, 1D, 2C, 3A, 3B, 4A, 5C, 6B, 6C, 8B, 9B, 9C, and 9D.
. 2021 Aug;100(2):65. doi: 10.1124/mol.109.061259retraction
Notice of Retraction: Acharya P, Chen J-J, Correia MA (2010) Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2α kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone. Mol Pharmacol 77(4):575–592; doi:10.1124/mol.109.061259.
Received 2021 May 20; Accepted 2021 May 20; Issue date 2021 Aug.
Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics
PMCID: PMC8382259 PMID: 34404736
This retracts the article "Hepatic Heme-Regulated Inhibitor (HRI) Eukaryotic Initiation Factor 2α Kinase: A Protagonist of Heme-Mediated Translational Control of CYP2B Enzymes and a Modulator of Basal Endoplasmic Reticulum Stress Tone" in volume 77 on page 575.